Literature DB >> 11770002

Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems.

F Martel1, E Keating, C Calhau, D Gründemann, E Schömig, I Azevedo.   

Abstract

Several transmembrane transporters of organic compounds are regulated by phosphorylation/dephosphorylation mechanisms. The aim of this study was to investigate the possible regulation of the human extraneuronal monoamine transporter, hEMT, by these mechanisms. The experiments were performed using HEK293 cells stably transfected with pcDNA3hEMT (293hEMT). The characteristics of hEMT-mediated uptake of [3H]1-methyl-4-phenylpyridinium ([3H]MPP+) were studied by incubating the cells at 37 degrees C for 1 min with 200 nM [3H]MPP+. Uptake of [3H]MPP+ by 293hEMT cells was not affected or only slightly reduced by modulators of protein kinase A, protein kinase C, or protein kinase G. It was not affected by an inhibitor of protein tyrosine kinase and was reduced by mitogen-activated protein kinase inhibitors. Uptake of [3H]MPP+ by 293hEMT cells was independent of extracellular Ca2+ and strongly reduced by Ca2+/calmodulin pathway inhibitors. Uptake of [3H]MPP+ by 293hEMT cells was strongly reduced in the presence of non-selective phosphodiesterase inhibitors (IBMX, caffeine, theophylline). The effect of IBMX was independent of extracellular Ca2+ its IC50 was found to be 82.0 microM (66.2-101.6 microM; n=4), and its inhibitory effect resulted from a significant decrease in the maximal velocity of [3H]MPP+ uptake, with no change in the Michaelis-Menten constant. [3H]MPP+ uptake was reduced by 8-methoxy-methyl-IBMX, a selective inhibitor of the Ca2+/calmodulin-dependent phosphodiesterase (PDE1), but not by zaprinast, a selective inhibitor of PDE5. Uptake of [3H]MPP+ by 293hEMT cells was strongly reduced by protein tyrosine phosphatase inhibitors, by an alkaline phosphatase inhibitor and, by contrast. showed an increase in the presence of exogenous alkaline phosphatase. In conclusion, these results suggest that hEMT is regulated by phosphorylation/dephosphorylation mechanisms, being active in the dephosphorylated state.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770002     DOI: 10.1007/s002100100476

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

Review 1.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

2.  Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.

Authors:  Aditi Mulgaonkar; Jürgen Venitz; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

3.  Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method.

Authors:  Svenja K Holle; Giuliano Ciarimboli; Bayram Edemir; Ute Neugebauer; Hermann Pavenstädt; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2011-04-27       Impact factor: 3.657

4.  Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells.

Authors:  Erik Rytting; Kenneth L Audus
Journal:  Biochem Pharmacol       Date:  2007-09-19       Impact factor: 5.858

5.  The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.

Authors:  Vivian Massmann; Bayram Edemir; Eberhard Schlatter; Rouvier Al-Monajjed; Saliha Harrach; Philipp Klassen; Svenja K Holle; Aleksandra Sindic; Marina Dobrivojevic; Hermann Pavenstädt; Giuliano Ciarimboli
Journal:  Pflugers Arch       Date:  2013-08-28       Impact factor: 3.657

6.  MPP+-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition.

Authors:  Tamara A M Mocking; Hubert J Sijben; Yimé W Vermeulen; Adriaan P IJzerman; Laura H Heitman
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 7.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

Review 8.  Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology.

Authors:  Elisa Lozano; Elisa Herraez; Oscar Briz; Virginia S Robledo; Jorge Hernandez-Iglesias; Ana Gonzalez-Hernandez; Jose J G Marin
Journal:  Biomed Res Int       Date:  2013-07-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.